Sinus infections and congestion bring pain and misery to millions of Americans. When the condition is chronic or recurs frequently and medications do little to provide relief, then innovative sinus treatments are often recommended. There are several different procedures available, each with the same goal in mind—to improve nasal obstruction and relieve nagging sinus symptoms like congestion, drainage and headaches.
In this office procedure, a balloon catheter is inserted through the nostrils into the sinus passages and gently inflated. This causes the sinus cavity openings to expand, allowing for better drainage. The balloon is then deflated and removed. This procedure is minimally invasive, provides fast relief, excellent results and a much quicker recovery. Many patients are able to return to work the next day.
Up to 90 percent of patients report a significant improvement in sinus symptoms following this procedure.1
Eustachian Tube Dilation
Eustachian Tube Balloon Dilation System is indicated to treat persistent Eustachian tube dysfunction (ETD), a condition in which pressure, pain, clogged or muffled sensations occur in the ear.
Dr. Pablo Stolovitzky is part of the research team2 working on obtaining FDA approval in the United States. He uses a catheter to insert a small balloon through the patient’s nose and into the Eustachian tube. Once inflated, the balloon opens up a pathway for mucus and air to flow through the Eustachian tube; this may help restore proper function. After the Eustachian tube is dilated the balloon is removed.
This Propel steroid-releasing implant is the first product on the market that targets the inflamed sinus tissues directly, opening them up for improved drainage and a reduction in symptoms.
The implant, inserted during an endoscopic sinus procedure, resembles a spring, and delivers a measured dose of mometasone furoate, an anti-inflammatory steroid that gradually dissolves. It is completely absorbed by the body four to six weeks after implantation, with lasting results.3
The Sinuva implant is designed for the in-office treatment of chronic sinusitis with polyps in patients who have had previous sinus surgery. Clinical research proved that the Sinuva implant is a safe and effective treatment for recurrent polyps.4 Dr. Pablo Stolovitzky was one of the National Principal Investigators in charge of Sinuva clinical trials.
This FDA approved medical device is used to treat chronic rhinitis in adults. It helps treat runny nose, nasal congestion and postnasal drip, which can be caused by out-of-balance nerves in the nose.
ClariFix uses a treatment method called cryotherapy to reduce symptoms. Unlike other treatments like nasal sprays and over-the-counter pills, it addresses the root of the problem—the inflamed nasal tissue and underlying nerves.
The device works by delivering cold temperatures to balance the nerves in the nose. This stops symptoms at the source. Four out of five patients report long-lasting improvement with ClariFix.5
LATERA® is an absorbable nasal implant used to support the upper and lower cartilage inside the lateral (side) wall of your nose. Supporting the cartilage may reduce nasal airway obstruction symptoms and help you breathe better.6 The implant is placed inside the nasal wall by an ear, nose, and throat specialist. Dr. Stolovitzky was one of the National Principal Investigators in charge of the LATERA clinical trials. Ask him if LATERA could be right for you.
A clinical study shows that LATERA patients demonstrate:
- Reduced nasal congestion or stuffiness
- Less trouble breathing through the nose
- Improved ability to get enough air through the nose during exercise or exertion
- Reduced nasal blockage or obstruction
- Less trouble sleeping
This procedure opens your nasal airway, thus eliminating symptoms caused by nasal obstruction. With minimal discomfort and no incisions, Vivaer can be performed in your doctor’s office. It has been clinically shown to significantly improve quality of life and provide long-lasting relief.
The results7 speak for themselves:
- 97 percent of patients experienced significant improvement in nasal breathing
- 94 percent of patients improved their ability to get enough air through their nose during exercise or exertion
- 89 percent of patients reported getting a better night’s sleep
The RhinAer® procedure is clinically demonstrated to improve symptoms in 96 percent of patients. Patients typically return to normal activity on the same day. Benefits8 include:
- Lasting relief of symptoms including runny nose, post-nasal drip, and chronic cough.
- Minimal discomfort, no incisions, and can be performed in your doctor’s office.
- Clinical studies show that patients treated with the RhinAer® procedure reported significant improvements in their symptoms and quality of life.
 Medical Therapy Versus Balloon Sinus Dilation in Adults with Chronic Rhinosinusitis (MERLOT): 12-Month Follow-up. Stolovitzky JP, Mehendale N, Matheny KE, et.al. A. Am J Rhinol Allergy. 2018 Jul;32(4):294-302
 Balloon Dilation of the Eustachian Tube: 12-Month Follow-up of the Randomized Controlled Trial Treatment Group. Anand V, Poe D, Dean M, Roberts W, Stolovitzky P, et.al. J. Otolaryngol Head Neck Surg. 2019 Apr;160(4):687-694
 Bioabsorbable steroid-releasing implants in the frontal sinus ostia: a pooled analysis. Singh A, Luong AU, Fong KJ, Ow RA, Han JK, Gerencer R, Stolovitzky JP, Stambaugh JW, Raman A. Int Forum Allergy Rhinol. 2019 Feb;9(2):131-139
 In-office Placement of Mometasone Furoate Sinus Implants for Recurrent Nasal Polyps: A Pooled Analysis. Stolovitzky JP, Kern RC, Han JK, et.al. Am J Rhinol Allergy. 2019 Sep;33(5):545-558.
 Hwang P, et al. “Cryosurgical Posterior Nasal Tissue Ablation for the Treatment of Rhinitis.” Int Forum Allergy Rhinol. 2017 Oct;7(10):952-956.
 Assessment of bioabsorbable implant treatment for nasal valve collapse compared to a sham group: a randomized control trial. Stolovitzky P, Senior B, Ow RA, et.al. Int Forum Allergy Rhinol. 2019 Aug;9(8):850-856.
 Data on file. Aerin Medical TR680-01.
 Effect of Radiofrequency Neurolysis on the Symptoms of Chronic Rhinitis: A Randomized Controlled Trial. Stolovitzky JP, Ow RA, Silvers SL, et.al. American Academy of Otolaryngology-Head and Neck Surgery. 2021; 5(3):1-7.